Up-Regulation of Interleukin-10 mRNA Expression in Peripheral Leukocytes Predicts Poor Outcome and Diminished Human Leukocyte Antigen-DR Expression on Monocytes in Septic Patients

Journal of Surgical Research

Volumn 147, Issue 1, 2008, Pages 1-8

  Abe, Ryuzo ^a   Hirasawa, Hiroyuki ^a   Oda, Shigeto ^a   Sadahiro, Tomohito ^a   Nakamura, Masataka ^a   Watanabe, Eizo ^a   Nakada, Taka Aki ^a   Hatano, Masahiko ^a   Tokuhisa, Takeshi ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

cytokine; gene expression; hypercytokinemia; immunoparalysis; sepsis

Indexed keywords

GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LEUKOCYTE; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEPSIS; UPREGULATION;

ADULT; AGED; FEMALE; GENE EXPRESSION REGULATION; HLA-DR ANTIGENS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; LEUKOCYTES; MALE; MIDDLE AGED; MONOCYTES; RNA, MESSENGER; SEPSIS; UP-REGULATION;

EID: 43049085950     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2007.07.009     Document Type: Article

References (33)

1. Hotchkiss R.S., and Karl I.E. The pathophysiology and treatment of sepsis. N Engl J Med 348 (2003) 138
2. Munford R.S., and Pugin J. Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Respir Crit Care Med 163 (2001) 316
3. Oberholzer A., Oberholzer C., and Moldawer L.L. Sepsis syndromes: Understanding the role of innate and acquired immunity. Shock 16 (2001) 83
4. Cohen J. The immunopathogenesis of sepsis. Nature 420 (2002) 885
5. Pinsky M.R., Vincent J.L., Deviere J., et al. Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 103 (1993) 565
6. Wang P., Wu P., Siegel M.I., et al. IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J Immunol 153 (1994) 811
7. Kox W.J., Volk T., Kox S.N., et al. Immunomodulatory therapies in sepsis. Intensive Care Med 26 Suppl 1 (2000) S124
8. Hynninen M., Pettila V., Takkunen O., et al. Predictive value of monocyte histocompatibility leukocyte antigen-DR expression and plasma interleukin-4 and -10 levels in critically ill patients with sepsis. Shock 20 (2003) 1
9. Giannoudis P.V., Smith R.M., Perry S.L., et al. Immediate IL-10 expression following major orthopaedic trauma: Relationship to anti-inflammatory response and subsequent development of sepsis. Intensive Care Med 26 (2000) 1076
10. Satoh A., Miura T., Satoh K., et al. Human leukocyte antigen-DR expression on peripheral monocytes as a predictive marker of sepsis during acute pancreatitis. Pancreas 25 (2002) 245
11. de Waal-Malefyt R., Haanen J., Spits H., et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression. J Exp Med 174 (1991) 915
12. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20 (1992) 864
13. Knaus W.A., Draper E.A., Wagner D.P., et al. APACHE II: A severity of disease classification system. Crit Care Med 13 (1985) 818
14. Vincent J.L., de Mendonca A., Cantraine F., et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: Results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European society of intensive care medicine. Crit Care Med 26 (1998) 1793
15. Oberholzer A., Souza S.M., Tschoeke S.K., et al. Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis. Shock 23 (2005) 488
16. Martin C., Boisson C., Haccoun M., et al. Patterns of cytokine evolution (tumor necrosis factor-α and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma. Crit Care Med 11 (1997) 1813
17. Oda S., Hirasawa H., Shiga H., et al. Sequential measurement of IL-6 blood levels in patients with systemic inflammatory response syndrome (SIRS)/sepsis. Cytokine 29 (2005) 169
18. Remick D.G., Bolgos G.R., Siddiqui J., et al. Six at six: Interleukin-6 measured 6 h after the initiation of sepsis predicts mortality over 3 d. Shock 17 (2002) 463
19. Watanabe E., Hirasawa H., Oda S., et al. Extremely high interleukin-6 blood levels and outcome in the critically ill are associated with tumor necrosis factor- and interleukin-1-related gene polymorphisms. Crit Care Med 33 (2005) 89 Discussion 242
20. Pachot A., Monneret G., Brion A., et al. Messenger RNA expression of major histocompatibility complex class II genes in whole blood from septic shock patients. Crit Care Med 33 (2005) 31 Discussion 236
21. Kalkoff M., Cursons R.T., Sleigh J.W., et al. The use of real time rtPCR to quantify inflammatory mediator expression in leukocytes from patients with severe sepsis. Anaesth Intensive Care 32 (2004) 746
22. Bustin S.A. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 25 (2000) 169
23. Overbergh L., Giulietti A., Valckx D., et al. The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression. J Biomol Tech 14 (2003) 33
24. Whitney A.R., Diehn M., Popper S.J., et al. Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci USA 100 (2003) 1896
25. Moore K.W., de Waal-Malefyt R., Coffman R.L., et al. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19 (2001) 683
26. Oberholzer A., Oberholzer C., and Moldawer L.L. Interleukin-10: A complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug. Crit Care Med 30 (2002) S58
27. Kawasaki T., Ogata M., Kawasaki C., et al. Surgical stress induces endotoxin hyporesponsiveness and an early decrease of monocyte mCD14 and HLA-DR expression during surgery. Anesth Analg 92 (2001) 1322
28. Tschaikowsky K., Hedwig-Geissing M., Schiele A., et al. Coincidence of pro- and anti-inflammatory responses in the early phase of severe sepsis: Longitudinal study of mononuclear histocompatibility leukocyte antigen-DR expression, procalcitonin, C-reactive protein, and changes in T-cell subsets in septic and postoperative patients. Crit Care Med 30 (2002) 1015
29. Monneret G., Finck M.E., Venet F., et al. The anti-inflammatory response dominates after septic shock: Association of low monocyte HLA-DR expression and high interleukin-10 concentration. Immunol Lett 95 (2004) 193
30. Fumeaux T., and Pugin J. Role of interleukin-10 in the intracellular sequestration of human leukocyte antigen-DR in monocytes during septic shock. Am J Respir Crit Care Med 166 (2002) 1475
31. Lekkou A., Karakantza M., Mouzaki A., et al. Cytokine production and monocyte HLA-DR expression as predictors of outcome for patients with community-acquired severe infections. Clin Diagn Lab Immunol 11 (2004) 161
32. Muller Kobold A.C., Tulleken J.E., Zijlstra J.G., et al. Leukocyte activation in sepsis; correlations with disease state and mortality. Intensive Care Med 26 (2000) 883
33. Perry S.E., Mostafa S.M., Wenstone R., et al. Is low monocyte HLA-DR expression helpful to predict outcome in severe sepsis?. Intensive Care Med 29 (2003) 1245